• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌患者根据门静脉肿瘤切除术方法的生存率是否存在差异?

Is there any difference in survival according to the portal tumor thrombectomy method in patients with hepatocellular carcinoma?

作者信息

Inoue Yosuke, Hasegawa Kiyoshi, Ishizawa Takeaki, Aoki Taku, Sano Keiji, Beck Yoshifumi, Imamura Hiroshi, Sugawara Yasuhiko, Kokudo Norihiro, Makuuchi Masatoshi

机构信息

Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.

出版信息

Surgery. 2009 Jan;145(1):9-19. doi: 10.1016/j.surg.2008.09.005.

DOI:10.1016/j.surg.2008.09.005
PMID:19081470
Abstract

BACKGROUND

Although portal venous tumor thrombus (PVTT) is regarded as an ominous prognostic factor in patients with hepatocellular carcinoma (HCC), the optimal treatment method for maximizing both safety and long-term outcome has not yet been discussed. We describe a surgical technique in which the venous wall is peeled off from the PVTT.

METHODS

In the peeling off (PO) technique, the portal venotomy was placed after adequate vascular control of portal flow. The PVTT was dissected from the portal venous wall and removed through the opening. Macroscopically residual PVTTs intruding into tiny branches were meticulously extracted. This procedure was compared with the en bloc resection of PVTT. Between 1995 and 2006, 49 patients underwent curative hepatic resections for HCC with macroscopic PVTT; these patients were classified according to whether the PO technique (n = 20) or the en bloc technique (n = 29) had been utilized. Both the short- and long-term results were compared between the 2 groups.

RESULTS

No mortalities occurred in either group. Both the 5-year overall survival and the recurrence-free survival rates of the PO group were comparable with those of the en bloc group (39% vs 41% [P = .90] and 23% vs 18% [P = .89], respectively). No local recurrences or regrowth of the PVTT occurred in either group.

CONCLUSION

Our procedure is useful for removing PVTT extending beyond the bifurcation or into other sectors that should be preserved in terms of liver function and enables a more conservative resection than an en bloc technique without sacrificing curability.

摘要

背景

尽管门静脉癌栓(PVTT)被视为肝细胞癌(HCC)患者预后不良的因素,但尚未讨论过能使安全性和长期疗效最大化的最佳治疗方法。我们描述了一种从PVTT上剥离静脉壁的手术技术。

方法

在剥离(PO)技术中,在充分控制门静脉血流后进行门静脉切开术。将PVTT从门静脉壁上剥离并通过开口取出。肉眼可见侵入小分支的残留PVTT被仔细取出。将该手术与PVTT整块切除进行比较。1995年至2006年期间,49例患有肉眼可见PVTT的HCC患者接受了根治性肝切除术;这些患者根据是否采用PO技术(n = 20)或整块技术(n = 29)进行分类。比较两组的短期和长期结果。

结果

两组均未发生死亡。PO组的5年总生存率和无复发生存率与整块切除组相当(分别为39%对41% [P = 0.90]和23%对18% [P = 0.89])。两组均未发生PVTT的局部复发或再生长。

结论

我们的手术方法有助于切除延伸至分叉以外或进入其他应保留肝功能的肝段的PVTT,并且能够比整块切除技术进行更保守的切除,同时不牺牲根治性。

相似文献

1
Is there any difference in survival according to the portal tumor thrombectomy method in patients with hepatocellular carcinoma?肝细胞癌患者根据门静脉肿瘤切除术方法的生存率是否存在差异?
Surgery. 2009 Jan;145(1):9-19. doi: 10.1016/j.surg.2008.09.005.
2
Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma.门静脉癌栓的位置及延伸对肝细胞癌手术治疗长期疗效的影响
Ann Surg Oncol. 2006 Jul;13(7):940-6. doi: 10.1245/ASO.2006.08.007. Epub 2006 May 23.
3
Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus.肝细胞癌合并门静脉癌栓的外科治疗。
Ann Surg Oncol. 2010 Aug;17(8):2073-80. doi: 10.1245/s10434-010-0940-4. Epub 2010 Feb 4.
4
Liver resection with portal vein thrombectomy for hepatocellular carcinoma with vascular invasion.伴有血管侵犯的肝细胞癌行肝切除联合门静脉取栓术
Ann Surg Oncol. 2009 May;16(5):1254. doi: 10.1245/s10434-009-0383-y. Epub 2009 Mar 10.
5
Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus.伴有门静脉癌栓的肝细胞癌的外科治疗
Hepatogastroenterology. 2006 May-Jun;53(69):415-9.
6
[Time dependency of factors influencing survival of hepatocellular carcinoma patients with portal vein tumor thrombosis after surgery].[手术后门静脉癌栓的肝细胞癌患者生存影响因素的时间依赖性]
Zhonghua Yi Xue Za Zhi. 2006 Nov 14;86(42):3005-8.
7
[Efficacy of postoperative chemotherapy combined with immunotherapy for hepatocellular carcinoma with major portal vein tumor thrombus].[术后化疗联合免疫治疗对伴主要门静脉癌栓肝细胞癌的疗效]
Zhonghua Wai Ke Za Zhi. 2007 Oct 1;45(19):1325-7.
8
[Hepatic resection with removal of tumor thrombi for hepatocellular carcinoma with tumor thrombi in portal vein and curative analysis].[门静脉癌栓型肝细胞癌肝切除并癌栓取出术及疗效分析]
Zhonghua Wai Ke Za Zhi. 1999 Jan;37(1):8-11.
9
Comparison of survival and quality of life of hepatectomy and thrombectomy using total hepatic vascular exclusion and chemotherapy alone in patients with hepatocellular carcinoma and tumor thrombi in the inferior vena cava and hepatic vein.比较肝切除术和血栓切除术在伴有下腔静脉和肝静脉肿瘤血栓的肝细胞癌患者中使用全肝血管阻断和单纯化疗的生存和生活质量。
Eur J Gastroenterol Hepatol. 2012 Feb;24(2):186-94. doi: 10.1097/MEG.0b013e32834dda64.
10
New macroscopic classification and back-flow thrombectomy for advanced hepatocellular carcinoma with portal vein tumor thrombus invading the contralateral second portal branch.伴有门静脉瘤栓侵犯对侧第二门静脉分支的晚期肝细胞癌的新宏观分类及回流血栓切除术
Surg Today. 2017 Sep;47(9):1094-1103. doi: 10.1007/s00595-017-1507-9. Epub 2017 Mar 21.

引用本文的文献

1
Liver resection in selective hepatocellular carcinoma with Vp3 or Vp4 portal vein tumor thrombosis improves prognosis.对伴有Vp3或Vp4门静脉癌栓的选择性肝细胞癌进行肝切除可改善预后。
J Liver Cancer. 2024 Mar;24(1):102-112. doi: 10.17998/jlc.2024.01.31. Epub 2024 Feb 14.
2
Management of potential portal vein thrombus during laparoscopic right hemihepatectomy following portal vein embolization.门静脉栓塞后腹腔镜右半肝切除术中潜在门静脉血栓的处理
Langenbecks Arch Surg. 2024 Feb 9;409(1):56. doi: 10.1007/s00423-024-03250-x.
3
Favorable Prognostic Factors for Survival Outcomes of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis After Hepatectomy.
肝癌合并门静脉癌栓患者术后生存结局的有利预后因素。
Ann Surg Oncol. 2023 Jul;30(7):4279-4289. doi: 10.1245/s10434-023-13316-7. Epub 2023 Apr 12.
4
Surgical resection for large hepatocellular carcinoma and those beyond BCLC: systematic review with proposed management algorithm.手术切除治疗大肝癌和巴塞罗那分期 C 期肝癌以外的肝癌:系统综述与提出的治疗方案算法。
Langenbecks Arch Surg. 2023 Apr 12;408(1):144. doi: 10.1007/s00423-023-02881-w.
5
Surgical management in hepatocellular carcinoma with portal vein tumour thrombosis: is this the end of the road or a chance to expand the criteria for resectability?伴有门静脉肿瘤血栓形成的肝细胞癌的外科治疗:这是道路的尽头还是扩大可切除标准的契机?
Prz Gastroenterol. 2022;17(4):257-265. doi: 10.5114/pg.2022.118138. Epub 2022 Jul 15.
6
Application and utility of surgical techniques for cystic plate isolation in liver surgery.肝手术中囊性板分离手术技术的应用及效用
Ann Gastroenterol Surg. 2022 Mar 22;6(5):726-732. doi: 10.1002/ags3.12568. eCollection 2022 Sep.
7
Comparison of Surgical Resection and Systemic Treatment for Hepatocellular Carcinoma with Vascular Invasion: National Cancer Database Analysis.伴有血管侵犯的肝细胞癌手术切除与全身治疗的比较:美国国立癌症数据库分析
Liver Cancer. 2021 Apr 23;10(5):407-418. doi: 10.1159/000515554. eCollection 2021 Sep.
8
Impact of Hepatectomy for Advanced Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombus.肝切除术对伴有主要门静脉癌栓的晚期肝细胞癌的影响
J Gastrointest Surg. 2022 Apr;26(4):822-830. doi: 10.1007/s11605-021-05181-0. Epub 2021 Oct 29.
9
Challenging the Treatment Paradigm: Selecting Patients for Surgical Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.挑战治疗模式:选择肝细胞癌伴门静脉癌栓手术治疗的患者
J Hepatocell Carcinoma. 2021 Jul 28;8:851-860. doi: 10.2147/JHC.S291530. eCollection 2021.
10
F-fluorodeoxyglucose PET/CT as an independent predictor for patients with hepatocellular carcinoma combined with major portal vein tumor thrombus.F-氟脱氧葡萄糖PET/CT作为肝细胞癌合并主要门静脉癌栓患者的独立预测指标。
Ann Surg Treat Res. 2020 Jul;99(1):8-17. doi: 10.4174/astr.2020.99.1.8. Epub 2020 Jun 29.